Thomas DiRaimondo's Insider Trades & SAST Disclosures

Thomas DiRaimondo's most recent trade in Janux Therapeutics Inc was a trade of 109,900 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.

Share

Note

This is a custom search result for pattern Thomas DiRaimondo.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Janux Therapeutics Inc	Thomas DiRaimondo	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2026	109,900	109,900	-		-	Stock option (right to buy)
Janux Therapeutics Inc	DiRaimondo Thomas	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2026	31,400	155,825	-		0	Common Stock
Janux Therapeutics Inc	Thomas DiRaimondo	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 13.73 per share.	02 Jan 2026	2,505	124,425	-	13.7	34,394	Common Stock
Janux Therapeutics Inc	Thomas DiRaimondo	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	84,000	84,000	-		-	Stock option (right to buy)
Janux Therapeutics Inc	Thomas DiRaimondo	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	24,000	129,719	-		0	Common Stock
Janux Therapeutics Inc	Thomas DiRaimondo	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 46.21 per share.	27 Sep 2024	4,325	98,613	-	46.2	199,840	Common Stock
Janux Therapeutics Inc	Thomas DiRaimondo	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 47.23 per share.	27 Sep 2024	675	97,938	-	47.2	31,877	Common Stock
Janux Therapeutics Inc	DiRaimondo Thomas	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	147,000	147,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades